ag真人平台官方
Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Prospectus
Announcements
2020.08.10
NOTICE OF THE 2020 THIRD EXTRAORDINARY GENERAL MEETING
2020.08.10
PROXY FORM FOR THE 2020 THIRD EXTRAORDINARY GENERAL MEETING TO BE HELD ON MONDAY...
2020.08.10
RE-ELECTION OF DIRECTORS OF THE FIFTH SESSION OF THE BOARD RE-ELECTION OF SUPERV...
2020.08.04
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3...
2020.08.01
RE-ELECTION OF DIRECTORS OF THE FIFTH SESSION OF THE BOARD RE-ELECTION OF SUPERV...
2020.07.31
STABILIZING ACTIONS, END OF STABILIZATION PERIOD AND LAPSE OF THE OVER-ALLOTMENT...
2020.07.14
INSIDE INFORMATION ANNOUNCEMENT REGARDING THE ESTIMATED RESULTS FOR THE FIRST HA...
2020.07.07
ARTICLES OF ASSOCIATION
2020.07.07
TERMS OF REFERENCE OF SPECIAL COMMITTEES OF THE BOARD OF DIRECTORS OF SHENZHEN H...
2020.07.07
TERMS OF REFERENCE OF SPECIAL COMMITTEES OF THE BOARD OF DIRECTORS OF SHENZHEN H...
第一页
上一页
17
18
19
20
21
下一页
最后一页